Table 1. siRNA sequences used in the study.

	Sense	Antisense
Lu25-a	5′-r(GAGGAGCCUUCAGGAUUACAAGAUU)-3′	5′-r(AAUCUUGUAAUCCUGAAGGCUCCUC)-3′
GFP-1	5′-r(GCUGACCCUGAAGUUCAUCUGCAUU)-3′	5′-r(AAUGCAGAUGAACUUCAGGGUCAGC)-3′
hmTF-25-1	5′-r(GGAUCCACGAGCCCAAGGGCUACCA)-3′	5′-r(UGGUAGCCCUUGGGCUCGUGGAUCC)-3′
hmTF-25-2	5′-r(GAGCACCAUUCUCCUUGAAAGGACU)-3′	5′-r(AGUCCUUUCAAGGAGAAUGGUGCUC)-3′
hmTF-25-3	5′-r(CCUCAAUUCAGUCUCUCAUCUGCAA)-3′	5′-r(UUGCAGAUGAGAGACUGAAUUGAGG)-3′
hmTF-25-4	5′-r(GAUCCACGAGCCCAAGGGCUACCAU)-3′	5′-r(AUGGUAGCCCUUGGGCUCGUGGAUC)-3′
hmTF-25-5	5′-r(CACGAGCCCAAGGGCUACCAUGCCA)-3′	5′-r(UGGCAUGGUAGCCCUUGGGCUCGUG)-3′
hmTF-25-6	5′-r(GAGGUCACCCGCGUGCUAAUGGUGG)-3′	5′-r(CCACCAUUAGCACGCGGGUGACCUC)-3′
hmTF-25-7	5′-r(GUACAACAGCACCCGCGACCGGGUG)-3′	5′-r(CACCCGGUCGCGGGUGCUGUUGUAC)-3′
hmTF-25-8	5′-r(GUGGAUCCACGAGCCCAAGGGCUAC)-3′	5′-r(GUAGCCCUUGGGCUCGUGGAUCCAC)-3′
hmCX-25-1	5′-r(GGUCUGGUGCCUGGUCUGAUGAUGU)-3′	5′-r(ACAUCAUCAGACCAGGCACCAGACC)-3′
hmCX-25-2	5′-r(GAGCACCAUUCUCCUUGAAAGGACU)-3′	5′-r(AGUCCUUUCAAGGAGAAUGGUGCUC)-3′
hmCX-25-3	5′-r(CCUCAAUUCAGUCUCUCAUCUGCAA)-3′	5′-r(UUGCAGAUGAGAGACUGAAUUGAGG)-3′
hmCX-25-4	5′-r(GAUGUUUGCAUUCUUUGCCCAGCAC)-3′	5′-r(GUGCUGGGCAAAGAAUGCAAACAUC)-3′
hmCX-25-5	5′-r(GUCUUUGGUCUGGUGCCUGGUCUGA)-3′	5′-r(UCAGACCAGGCACCAGACCAAAGAC)-3′
hmCX-25-6	5′-r(GUGCCUGGUCUGAUGAUGUAUGCCA)-3′	5′-r(UGGCAUACAUCAUCAGACCAGGCAC)-3
hmCX-25-7	5′-r(CACCAUUCUCCUUGAAAGGACUUAU)-3′	5′-r(AUAAGUCCUUUCAAGGAGAAUGGUG)-3′
hmCX-25-8	5′-r(CAAUUCAGUCUCUCAUCUGCAAUAA)-3′	5′-r(UUAUUGCAGAUGAGAGACUGAAUUG)-3′

Lu25: siRNA targeting Luciferase; GFP-1: siRNA targeting Green Fluorescence Protein; hmTF (X): siRNAs targeting human TGF-beta1; huCX (X): siRNAs targeting human COX-2.